The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>”
<div><p>Vaccines need to be rationally designed in order be delivered to the immune system for maximizing induction of dynamic immune responses. Virus‐like particles (VLPs) are ideal platforms for such 3D vaccines, as they allow the display of complex and native antigens in a highly repe...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513511761117184 |
|---|---|
| author | Mona O. Mohsen (4056964) |
| author2 | Gilles Augusto (14597288) Martin F. Bachmann (7116422) |
| author2_role | author author |
| author_facet | Mona O. Mohsen (4056964) Gilles Augusto (14597288) Martin F. Bachmann (7116422) |
| author_role | author |
| dc.creator.none.fl_str_mv | Mona O. Mohsen (4056964) Gilles Augusto (14597288) Martin F. Bachmann (7116422) |
| dc.date.none.fl_str_mv | 2020-05-30T06:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1111/imr.12863 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/The_i_3Ds_i_in_virus_like_particle_based_vaccines_i_Design_Delivery_and_Dynamics_i_/26020861 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Immunology Medical biotechnology Pharmacology and pharmaceutical sciences delivery design dynamics vaccine virus-like particles |
| dc.title.none.fl_str_mv | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <div><p>Vaccines need to be rationally designed in order be delivered to the immune system for maximizing induction of dynamic immune responses. Virus‐like particles (VLPs) are ideal platforms for such 3D vaccines, as they allow the display of complex and native antigens in a highly repetitive form on their surface and can easily reach lymphoid organs in intact form for optimal activation of B and T cells. Adjusting size and zeta potential may allow investigators to further fine‐tune delivery to lymphoid organs. An additional way to alter vaccine transfer to lymph nodes and spleen may be the formulation with micron‐sized adjuvants that creates a local depot and results in a slow release of antigen and adjuvant. Ideally, the adjuvant in addition stimulates the innate immune system. The dynamics of the immune response may be further enhanced by inclusion of Toll‐like receptor ligands, which many VLPs naturally package. Hence, considering the 3Ds in vaccine development may allow for enhancement of their attributes to tackle complex diseases, not usually amenable to conventional vaccine strategies.</p><p> </p></div><h2>Other Information</h2> <p> Published in: Immunological Reviews<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1111/imr.12863" target="_blank">https://dx.doi.org/10.1111/imr.12863</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_22ebae8b9a997b980c29ca8f1b33c5fc |
| identifier_str_mv | 10.1111/imr.12863 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/26020861 |
| publishDate | 2020 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>”Mona O. Mohsen (4056964)Gilles Augusto (14597288)Martin F. Bachmann (7116422)Biomedical and clinical sciencesImmunologyMedical biotechnologyPharmacology and pharmaceutical sciencesdeliverydesigndynamicsvaccinevirus-like particles<div><p>Vaccines need to be rationally designed in order be delivered to the immune system for maximizing induction of dynamic immune responses. Virus‐like particles (VLPs) are ideal platforms for such 3D vaccines, as they allow the display of complex and native antigens in a highly repetitive form on their surface and can easily reach lymphoid organs in intact form for optimal activation of B and T cells. Adjusting size and zeta potential may allow investigators to further fine‐tune delivery to lymphoid organs. An additional way to alter vaccine transfer to lymph nodes and spleen may be the formulation with micron‐sized adjuvants that creates a local depot and results in a slow release of antigen and adjuvant. Ideally, the adjuvant in addition stimulates the innate immune system. The dynamics of the immune response may be further enhanced by inclusion of Toll‐like receptor ligands, which many VLPs naturally package. Hence, considering the 3Ds in vaccine development may allow for enhancement of their attributes to tackle complex diseases, not usually amenable to conventional vaccine strategies.</p><p> </p></div><h2>Other Information</h2> <p> Published in: Immunological Reviews<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1111/imr.12863" target="_blank">https://dx.doi.org/10.1111/imr.12863</a></p>2020-05-30T06:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1111/imr.12863https://figshare.com/articles/journal_contribution/The_i_3Ds_i_in_virus_like_particle_based_vaccines_i_Design_Delivery_and_Dynamics_i_/26020861CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/260208612020-05-30T06:00:00Z |
| spellingShingle | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” Mona O. Mohsen (4056964) Biomedical and clinical sciences Immunology Medical biotechnology Pharmacology and pharmaceutical sciences delivery design dynamics vaccine virus-like particles |
| status_str | publishedVersion |
| title | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” |
| title_full | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” |
| title_fullStr | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” |
| title_full_unstemmed | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” |
| title_short | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” |
| title_sort | The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>” |
| topic | Biomedical and clinical sciences Immunology Medical biotechnology Pharmacology and pharmaceutical sciences delivery design dynamics vaccine virus-like particles |